CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$22.51
arrow_upward
+1.49%(+0.33) 1D
Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
$22.50
High
$23.13
Low
$22.36
Mkt. cap
12.39T
Avg. vol.
372.86K
Volume
0.00
52-wk high
$34.84
52-wk low
$18.33
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
Open
$22.50
High
$23.13
Low
$22.36
Mkt. cap
12.39T
Avg. vol.
372.86K
Volume
0.00
52-wk high
$34.84
52-wk low
$18.33
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
9 minutes ago
Traders work on the floor of the NYSE in New York
Opening Bell Daily
·
10 minutes ago
Berkshire stock: up 18% in 2026, ahead of the S&P 500
Quantisnow
·
15 minutes ago
CELLYAN BIOTECHNOLOGY CO., LTD REGAINS COMPLIANCE WITH NASDAQ...
Reuters
·
1 hour ago
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitechugai-pharm.co.jp